US states sue OxyContin maker over opioid crisis

May 16, 2018

Six US states sued OxyContin maker Purdue Pharma on Tuesday for alleged deceptive trade practices related to its marketing of the opioid painkiller.

The coordinated but separately filed lawsuits were part of a wave of similar actions taken by and municipalities throughout the United States in connection with an drug abuse crisis that costs thousands of lives a year and has increased heroin addiction.

"My office is holding Purdue Pharma accountable for fueling the nation's opioid epidemic by deceptively marketing including OxyContin when it knew their drugs were potentially dangerous," Texas Attorney General Ken Paxton said.

Attorneys general of five other states—Nevada, Florida, North Carolina, North Dakota and Tennessee—also filed lawsuits against Purdue Pharma on Tuesday.

Florida sued additional companies, including Endo Pharmaceuticals and several drug distributors.

A bipartisan group of 41 state attorneys general also is conducting an investigation into whether opioid drug manufacturers and distributors broke the law.

In October, President Donald Trump described the opioid crisis as a national public health emergency. An estimated 2.4 million Americans are addicted to narcotics including prescription painkillers and heroin.

There were more than 42,000 opioid overdoses nationwide in 2016, and a death toll that has quadrupled over the last two decades, according to the Centers for Disease Control.

Pop icon Prince and rocker Tom Petty are among the most high profile victims.

Purdue Pharma said in February that it had told its salespeople to no longer encourage doctors to prescribe anti-pain medications such as OxyContin.

The company did not immediately respond to a request for comment.

Explore further: 6 US states accuse opioid maker Purdue of fueling overdoses

Related Stories

6 US states accuse opioid maker Purdue of fueling overdoses

May 15, 2018
Six U.S. states on Tuesday sued the maker of the opioid OxyContin of using deceptive marketing to boost drug sales that fueled opioid overdose deaths.

Alabama files lawsuit against opioid manufacturer

February 6, 2018
Alabama on Tuesday filed a lawsuit against the manufacturer of OxyContin and other opioids, becoming the latest state seeking to hold drug companies accountable for an addiction epidemic.

Opioid maker changes tack as scrutiny mounts

February 14, 2018
Accused of profiting from a deadly opioid crisis ravaging middle class America, the maker of the world's best-selling pain medication, Purdue Pharma, said Tuesday it is changing tack in the face of increasing scrutiny.

Study links rising heroin deaths to 2010 OxyContin reformulation

April 9, 2018
Efforts by Purdue Pharma in 2010 to make its blockbuster prescription opioid painkiller OxyContin less prone to abuse did nothing to reduce the number of drug overdose deaths across the nation. In fact, according to researchers ...

Ohio sues five drugmakers over role in opioid crisis

May 31, 2017
The US state of Ohio on Wednesday sued five major producers of prescription opioid medications, accusing them of lying about the deadly risks the painkillers—at the center of a nationwide addiction crisis—posed to public ...

New York hits big pharma with $500mn lawsuit in opioid crisis

January 23, 2018
New York turned the screws on pharmaceutical giants in America's opioid epidemic, suing manufacturers for $500 million on Tuesday as a photographer kickstarted a petition to hold Purdue Pharma accountable as a recovering ...

Recommended for you

Could nonprofit drug companies cut sky-high prices?

May 17, 2018
(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Fewer antibiotics for kids, but more ADHD drugs

May 15, 2018
(HealthDay)—American kids are taking fewer prescription medications these days—but certain drugs are being prescribed more than ever, a new government study finds.

Opioid makers' perks to docs tied to more prescriptions

May 14, 2018
Doctors who accept perks from companies that make opioid painkillers are more likely to prescribe the drugs for their patients, new research suggests.

Less is more when it comes to prescription opioids for hospital patients, study finds

May 14, 2018
In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital patients. By delivering the opioids with a shot under the skin or with a pill instead ...

Generic options provide limited savings for expensive drugs

May 7, 2018
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released today in its May issue.

Prescription drug monitoring programs may have negative unintended consequences

May 7, 2018
Prescription drug monitoring programs (PDMPs) are a key component of the President's Prescription Drug Abuse Prevention Plan and considered a critical tool for reducing prescription opioid-related illness and death. The results ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.